QR код

In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein

The recent development and mass administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines allowed for disease control, reducing hospitalizations and mortality. Most of these vaccines target the SARS-CoV-2 Spike (S) protein antigens, culminating with the production of ne...

Повний опис

Збережено в:
Автори: Bruna Andersen Pereira de Jesus, Anderson Albino Gomes, Alex E. Clark, Tayse Andrade Rodrigues, Melissa Ledgerwood-Lee, Westley Van Zant, Howard Brickner, Meiqiao Wang, David L. Blum, Maria B. Cassera, Aaron F. Carlin, Eliah S. Aronoff-Spencer, Gustavo Felippe da Silva, Maria de Lourdes Borba Magalhães, Partha Ray
Формат: Artigo
Мова:Inglês
Опубліковано: MDPI AG 2022-12-01
Серія:Viruses
Предмети:
SARS-CoV-2
spike protein
ACE2
engineered mini-protein
neutralizing antibodies
in vitro diagnostics
Онлайн доступ:https://www.mdpi.com/1999-4915/14/12/2823
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси